Citizen Petition from GenBioPro, Inc.

Physicians for Human Rights (PHR) supports the citizen petitions requesting that the FDA refrain from imposing additional restrictions on mifepristone. They argue that the drug is safe and effective based on extensive clinical evidence and that the review process should be grounded in scientific rigor rather than partisan politics.

Erin Witte opposes the proposed action to weaken safety protocols and remove Risk Evaluation and Mitigation Strategy (REMs) requirements for mifepristone. The commenter argues that the drug poses significant health risks and should be subject to strict regulation to protect women's lives.

William J. Hickey opposes the FDA's proposal to weaken safety protocols and remove Risk Evaluation and Mitigation Strategy (REMs) requirements for mifepristone. He argues that the drug poses significant health risks and should be subject to strict regulation to protect women.

Robert Smith opposes the proposed action to weaken safety protocols and remove Risk Evaluation and Mitigation Strategy (REMs) requirements for mifepristone. He argues that the drug poses significant risks to women's health and should be subject to strict regulation and robust safety measures.

Vincent Barrett opposes the proposed action to weaken safety protocols and remove Risk Evaluation and Mitigation Strategy (REMs) requirements for mifepristone. He argues that the drug poses significant health risks and should be subject to strict regulation to protect women.

Thomas Insinna opposes the FDA's proposal to weaken safety protocols and remove Risk Evaluation and Mitigation Strategy (REMs) requirements for mifepristone. He argues that the drug poses significant risks to women's health and should be subject to strict regulation and robust safety measures.